Minjiang Chen

23PUBLICATIONS

56CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical genetics (excl. cancer genetics)Predictive and prognostic markersMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (23)

Sort by Publication Date:

|Jul 13, 2026

Divergent Tumor Immune Microenvironment and Response to Neoadjuvant Chemoimmunotherapy in Resectable Non-Small Cell Lung Cancer: A Single-Arm Phase II Trial.

|Feb 11, 2026

Subcutaneously Administered Tislelizumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Pharmacokinetics and Safety Results from the BGB-A317-103 Phase I Study.

Minjiang Chen, Iurie Bulat, Marina Maglakelidze

|May 02, 2025

Real-World Analysis of Treatment Patterns in Limited-Stage Small Cell Lung Cancer: Implications for Clinical Practice.

Siyuan Yu, Xiaoyi Feng, Shengjie Li

|Mar 21, 2025

Safety and Efficacy of Radiotherapy Combined With Sintilimab in Advanced NSCLC Patients Who Progressed on First or Second Line Therapy: A Prospective, Multiple Center, and Single-Arm Study.

Xiaoyi Feng, Xiaoyan Liu, Hui Guan

|Oct 29, 2024

Characterization of renal injury in non-squamous non-small cell lung cancer patients treated with pemetrexed: A single-center retrospective study.

Yang Wu, Kang Miao, Minjiang Chen

|Sep 29, 2024

Remarkable pathological response to neoadjuvant tepotinib in lung adenocarcinoma with MET exon 14 skipping mutation: A case report.

Rongzhen Li, Xiaoyan Liu, Yan Xu

Pageof 4

Frequent Collaborators

20 joint publications

Yan Xu

Yuequan Shi

Xiaoyan Si

Xiaotong Zhang

Mengzhao Wang

Hanping Wang

Li Zhang

Bei Tan

Hongge Liang

Jia Liu

Frequent Collaborators

20 joint publications

Yan Xu

5 joint publications

Yuequan Shi

5 joint publications

Xiaoyan Si

5 joint publications

Xiaotong Zhang